A detailed history of Farther Finance Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 212 shares of COLL stock, worth $8,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
212
Previous 43 393.02%
Holding current value
$8,416
Previous $1.67 Million 313.58%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$31.36 - $39.99 $5,299 - $6,758
169 Added 393.02%
212 $6.92 Million
Q1 2024

May 13, 2024

SELL
$31.23 - $40.91 $1,780 - $2,331
-57 Reduced 57.0%
43 $1.67 Million
Q4 2023

Feb 14, 2024

SELL
$21.16 - $30.8 $1,206 - $1,755
-57 Reduced 57.0%
43 $1.32 Million
Q1 2023

May 13, 2024

BUY
$23.0 - $29.88 $1,311 - $1,703
57 Added 132.56%
100 $2.4 Million
Q4 2022

Sep 11, 2023

BUY
$16.14 - $23.55 $1,614 - $2,355
100 New
100 $2.32 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.35B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.